News & Updates
Filter by Specialty:
Apixaban cheaper, on par with enoxaparin as VTE prophylaxis in gynaecologic cancer patients
Patients with gynaecologic cancer who used apixaban for postoperative venous thromboembolism (VTE) prophylaxis achieve similar 90-day and lower 30-day rates of VTE when compared with those who used enoxaparin, reports a study presented at SGO 2024.
Apixaban cheaper, on par with enoxaparin as VTE prophylaxis in gynaecologic cancer patients
12 Apr 2024
Antihypertensive drugs help prevent dementia in older adults
Use of antihypertensive medications can help reduce the risk of dementia among older people in the general population, results of a study have shown. In addition, the same benefit extends to the very old and frail patients.
Antihypertensive drugs help prevent dementia in older adults
11 Apr 2024
Bevacizumab + EGFR-TKI improves OS in EGFR-mutated NSCLC with leptomeningeal metastases
Adding bevacizumab to an EGFR tyrosine kinase inhibitor (TKI) improves overall survival (OS) in adult patients with EGFR-mutated non-small-cell lung cancer (NSCLC) and leptomeningeal metastases (LMs), according to a single-centre, retrospective, real-world study in China. OS was, however, similar between patients on chemotherapy plus EGFR-TKI and those on EGFR-TKI monotherapy.